Find Faculty
Yousaf Ali, MBBS
img_Yousaf Ali
PROFESSOR | Medicine, Rheumatology
Are you a patient?
View my
Provider Profile
Specialties
Internal Medicine, Rheumatology
New topic

Dr Ali is currently PI on several trials investigating new treatments for SLE and RA. He is also developing a patient centric app to predict flares in RA that should improve care and outcome.

Embrace Study: phase 3/4, multi-center, randomized, double-blind, placebo-controlled,52-week study to evaluate the efficacy and safety of belimumab (HGS1006) in adult subjects of black race with SLE

 

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of CNTO 136 (sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Subjects with Active Rheumatoid Arthritis Despite Anti-TNF Therapy

BM, Royal Free Hospital School of Medicine

MD, Royal Free Hospital School of Medicine. University of London

Residency, Internal Medicine, Oregon Health & Science University-OHSU GME

Certifications

American Board of Internal Medicine

2021

Institute for Medical Education (IME) Award - Master Clinician

Icahn School of Medicine at Mount Sinai

2021

Cullman Family Award for Excellence in Physician Communication

Mount Sinai Health System

2017

Stanley G. Seckler Award for Clinical and Educational Excellence in Medicine

2014

Best Doctors in NY

2007

Best Doctors in Rhode Island

2006

Beckwith Family Award for outstanding teaching

Brown University

2004

Teaching Recognition Award

Brown university

2001

Preceptor Award

Brown University

Top Doctors in New York

Castle Connelly

23
Publications

Selected Publications

Assessing Changes in Vascular Inflammation and Urate Deposition in the Vasculature of Gout Patients After Administration of Pegloticase Using Positron Emission Tomography and Dual-Energy Computed Tomography—A Pilot Study. Ira Khanna, Venkatesh Mani, Renata Pyzik, Audrey Kaufman, Weiwei Chi, Emilia Bagiella, Philip Robson, Yousaf Ali. Gout, Urate, and Crystal Deposition Disease

Prevalence of cardiovascular events in a population-based registry of patients with systemic lupus erythematosus. Daniel P. Joyce, Jeffrey S. Berger, Allison Guttmann, Ghadeer Hasan, Jill P. Buyon, H. Michael Belmont, Jane Salmon, Anca Askanase, Joan Bathon, Laura Geraldino-Pardilla, Yousaf Ali, Ellen M. Ginzler, Chaim Putterman, Caroline Gordon, Charles G. Helmick, Kamil E. Barbour, Heather T. Gold, Hilary Parton, Peter M. Izmirly. Arthritis Research and Therapy

Prevalence of concomitant rheumatologic diseases and autoantibody specificities among racial and ethnic groups in SLE patients. Brendan Denvir, Philip M. Carlucci, Kelly Corbitt, Jill P. Buyon, H. Michael Belmont, Heather T. Gold, Jane E. Salmon, Anca Askanase, Joan M. Bathon, Laura Geraldino-Pardilla, Yousaf Ali, Ellen M. Ginzler, Chaim Putterman, Caroline Gordon, Kamil E. Barbour, Charles G. Helmick, Hilary Parton, Peter M. Izmirly. Frontiers in Epidemiology

View All Publications

Hyperuricemia: The Good, the Bad and the Ugly

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Ali during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Medical Education Resources (MER)

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.